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Aims This study compared the myocardial ischaemic burden (MIB) in patients with angiographic three-vessel coronary artery
disease (3VD) using high-resolution and standard-resolution myocardial perfusion cardiovascular magnetic resonance
(perfusion CMR) imaging.
Methods
and results
One hundred and five patients undergoing coronary angiography had two separate stress/rest perfusion CMR studies,
one with standard-resolution (2.5 mm in-plane) and another with high-resolution (1.6 mm in-plane). Quantitative cor-
onary angiographywasused todefinepatientswith angiographic 3VD.PerfusionCMR imageswereanonymized, random-
ly ordered and visually reported by two observers acting in consensus and blinded to all clinical and angiographic data.
Perfusion was graded in each segment on a four-point scale and summed to produce a perfusion score and estimate
ofMIB for each patient. In patientswith angiographic 3VD (n ¼ 35), high-resolution acquisition identifiedmore abnormal
segments (7.2+ 3.8 vs. 5.3+4.0; P ¼ 0.004) and territories (2.4+0.9 vs. 1.6+ 1.1; P ¼ 0.002) and a higheroverall per-
fusion score (20.1+7.7 vs. 11.9+ 9.4; P, 0.0001) per patient comparedwith standard-resolution. The number of seg-
ments with subendocardial ischaemia was greater with high-resolution acquisition (195 vs. 101; P, 0.0001).
Hypoperfusion in all three territories was identified in 57% of 3VD patients by high-resolution compared with only
29% by standard-resolution (P ¼ 0.04). The area-under-the-curve (AUC) for detecting angiographic 3VD using the esti-
mated MIB was significantly greater with high-resolution than standard-resolution acquisition (AUC ¼ 0.90 vs. 0.69;
P, 0.0001).
Conclusion In patients with angiographic 3VD, the ischaemic burden detected by perfusion CMR is greater with high-resolution ac-
quisition due to better detection of subendocardial ischaemia. High-resolution perfusion CMR may therefore be pre-
ferred for risk stratification and management of this high-risk patient group.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords coronary artery disease † magnetic resonance imaging † ischaemia † myocardial perfusion imaging
Introduction
Three-vessel coronary artery disease (3VD) is found in 9% of
patients undergoing elective coronary angiography and these
patients have a considerably poorer prognosis than those with less
extensive disease.1 Detection of 3VD with non-invasive imaging
can be challenging due to the effects of balanced ischaemia leading
to false-negative results in up to 20% of cases.2,3 This limitation has
been well documented with single-photon emission computed tom-
ography (SPECT), and although its overall sensitivity for detecting
* Corresponding author. Tel: +44 113 3437720; Fax: +44 113 3436603, Email: s.plein@leeds.ac.uk
& The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which
permits non-commercial re-use, distribution, and reproduction in anymedium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@
oup.com
European Heart Journal – Cardiovascular Imaging (2014) 15, 701–708
doi:10.1093/ehjci/jet286
 at Zentralbibliothek on Septem
ber 10, 2014
http://ehjcimaging.oxfordjournals.org/
D
ow
nloaded from
 
coronary artery disease (CAD) in multi-vessel disease is 80–95%, it
often only detects perfusion defects in one territory.2,4,5 In one
SPECT study, inducible perfusion abnormalities in all three territories
were identified inonly 12%of patientswith known angiographic 3VD.6
Myocardial perfusion cardiovascular magnetic resonance (perfu-
sion CMR) imaging is a highly accurate method for the detection of
significant CAD.7–9 One of the major advantages of perfusion
CMR compared with SPECT is its higher spatial resolution (typically
2–3 vs. 8–10 mm). Balanced ischaemia can lead to diffuse subendo-
cardial hypoperfusion and although there are few comparisons
between perfusion CMR and SPECT in 3VD, it is expected that the
higher resolutionofCMRcanbetter resolve the transmuralperfusion
gradient in balanced ischaemia and thereby potentially improve the
detection of 3VD.10 With recently developed spatio-temporal
undersampling methods such as k-t broad-use linear acquisition
speed-up technique (k-t BLAST), the spatial resolution of perfusion
CMR can be improved further to ,2 mm.11
Several studies have demonstrated the feasibility and accuracy of
high-resolution perfusion CMR.12–16 In a direct comparison, we have
previously shown that high-resolution perfusion CMR has a higher
overall diagnostic accuracy compared with standard-resolution
imaging in patients with suspected CAD. This previous study included
a small subset of patients with multi-vessel disease.16 The present
study aims to compare the distribution of and extent of ischaemia in
patientswith3VDdetectedbybothtechniquesandteststhehypothesis
that improvedperformanceofhigh-resolutionCMRisdue tobetterde-
tection of subendocardial ischaemia in 3VD.
Methods
Study population
A total of 105 patients were included in this analysis. All had undergone
coronary angiography for suspected angina within the last 30 days.
Seventy patients were prospectively recruited: 35 had 3VD on quantita-
tive coronary angiography and 35 with normal coronary arteries served
as a control group. Data from 24 of the patients with angiographic 3VD
have been previously reported with different endpoints (diagnostic ac-
curacy rather than pattern of ischaemia or ischaemic burden).16 Add-
itionally, we selected 35 consecutive patients with angiographic 1VD or
2VD fromthe sameprevious study toprevent a spectrumbias for the sec-
ondary analyses relating to myocardial ischaemic burden (MIB).16 Exclu-
sion criteria for all patients were contra-indications to CMR, adenosine,
or gadolinium contrast agent; or a history of recent (within 6 months)
myocardial infarction (MI), unstable angina, or revascularization. Add-
itionally, patients with angiographic 1VD or 2VD and co-existing moder-
ate coronary artery stenoses (i.e. 40–69%) in other territories were not
included.All patients gavewritten consent and the studywasapprovedby
the regional ethics committee.
CMR protocol
All patients underwent a standard-resolution and a high-resolution per-
fusion scan on separate days (within 4 weeks) using a 1.5-T scanner
(Intera, Philips Healthcare, Best, The Netherlands).
The standard perfusion pulse sequence was a saturation recovery
gradient-echo method accelerated with sensitivity encoding (SENSE)
(SENSE acceleration factor 2, repetition time (TR) 2.7 ms, echo time
(TE) 1.0 ms, flip-angle ¼ 158, acquisition time per slice ¼ 136 ms, single-
saturation pre-pulse per R–R interval shared over three slices, matrix ¼
144 × 144, median field-of-view (FOV) ¼ 360 mm, in-plane spatial
resolution ¼ 2.5 mm). The high-resolution perfusion pulse sequence
used a similar saturation recovery gradient-echo method, but was accel-
erated with k-t BLAST (acceleration factor 8 with 11 training profiles,
TR ¼ 3.4 ms, TE ¼ 1.7 ms, flip-angle ¼ 158, one saturation pre-pulse
per slice, acquisition time per slice ¼ 103 ms, matrix ¼ 192 × 192,
median FOV ¼ 310 mm, in-plane spatial resolution ¼ 1.6 mm). For
both techniques, perfusion data were acquired in three short-axis
slices in each R–R interval.
For both studies, stress perfusion started after 4 min of an intravenous
adenosine infusion (140 mcg/kg/min) during an intravenous bolus injec-
tion of dimeglumine gadopentetate (Magnevist; Schering AG, West
Sussex, UK) and a 15-mL saline flush delivered at 5 mL/s. Contrast
dose and administration protocols for both studies were chosen to
optimize their visual analysis performance based on their use in previous
studies. For the standard-resolution method, a contrast dose of
0.05 mmol/kg body weight was used during perfusion acquisition, identi-
cal to previous studies with this pulse sequence.9,16 To compensate for
the lower signal-to-noise ratio (SNR) associated with smaller voxel
size, a contrast dose of 0.1 mmol/kg body weight was used for the high-
resolution method, consistent with previous reports.13,14,16,17
Rest perfusion imaging was performed 15 min later. Late gadolinium-
enhancement (LGE) imaging was performed in all patients on their first
visit using conventional methods (1.6 mm in-plane spatial resolution)
and a cumulative contrast dose of 0.2 mmol/kg body weight (the same
for both protocols). During standard-resolution perfusion CMR scans,
this cumulative dosewas achieved by administration of an additional con-
trast bolus of 0.1 mmol/kg body weight immediately after rest perfusion.
CMR analysis
CMR images were anonymized, randomly ordered and visually reported
by twoobservers (S.P. andM.M., 10 and 2 years experience, respectively)
acting in consensus and blinded to all clinical and angiographic data
(QMASS6.1.6,Medis, Leiden, TheNetherlands). In caseof disagreement,
arbitration from a third observer was sought (J.P.G., 10 years ex-
perience).Using a 16-segmentmodel, perfusion in a segmentwas consid-
ered abnormal if signal intensity was reduced compared with remote
myocardium or an endocardial-to-epicardial perfusion gradient was
present.12,18 Additionally, any perfusion defect was required to persist
beyond the peak myocardial signal enhancement to distinguish it from
artefact. Corresponding LGE images were reviewed side-by-side with
theperfusiondata. Perfusiondefects present at stress but not rest andoc-
curring outside any hyperenhanced myocardial tissue on LGE images
were considered as inducible defects. Perfusion in each segment was
graded on a four-point scale (transmural ischaemia index: 0 ¼ normal,
1 ¼ inconclusive, 2 ¼ subendocardial defect, 3 ¼ transmural defect). A
typical example of perfusion images is seen in Figure 1. All segmental
scores were summed to produce a perfusion score (0–48) for each
patient. MIB as a percentage of the total myocardium (MIB%) was esti-
mated by dividing the perfusion score by 48 and multiplying by 100.19
In patients with 3VD, perfusion scores were also calculated for the left
anterior descending (LAD), left circumflex (LCX) and right coronary
artery (RCA) territories according to american heart association
(AHA) segmentation adjusted for arterial dominance.18
Imagequalitywasgraded1–4 (1 ¼ unusable, 2 ¼ poor, 3 ¼ adequate,
4 ¼ excellent). Occurrence of artefacts related to k-t reconstruction, re-
spiratory motion, electrocardiographic gating, and endocardial dark-rim
was scored 0–3 (0 ¼ none, 1 ¼ minor, 2 ¼ moderate, 3 ¼ severe).
Where present, the width of dark-rim artefact (DRA) (a frequent
finding in perfusionCMRat themyocardial–blood pool interface relating
to cardiac motion, Gibb’s ringing, susceptibility, and partial volume
cancellation) was measured with electronic callipers.16,20
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Quantitative coronary angiography
Quantitative coronary angiography (QCA) was performed (QCAPlus,
Sanders Data Systems, Palo Alto, CA, USA) by an experienced observer
blinded to CMR data (M.M., 7years of experience in coronary angiog-
raphy). Stenoses were assigned to the appropriate myocardial segments
of anAHA16-segmentmodel using standard criteria adjusted for arterial
dominance and lesion location.18,21 As per convention, significant CAD
was defined as luminal stenosis ≥70% in any of the major epicardial cor-
onary arteries or first-order branches ≥2 mm. Angiographic 3VD was
defined as stenosis ≥70% in all three coronary arteries; or the presence
of ≥50% stenosis in the left main stem with ≥70% in the RCA. Normal
coronary arterieswere defined as an absence of any stenosis≥40%.Col-
lateral circulation was graded according to the Rentrop classification
(RC) depending on the angiographic findings of the occluded artery
using the best injection: 0 ¼ no collateral circulation; 1 ¼ collateral
filling of side branches without visualization of any epicardial segments;
2 ¼ collaterals partially filling the epicardial segment; 3 ¼ collaterals
completely filling the epicardial segment.22
Statistical analysis
Analysis was performed using SPSS 17.0 (SPSS, Chicago, IL, USA). Mean
values were compared using paired Student t-tests. Ordinal data were
compared using x2 or Wilcoxon signed-rank tests as appropriate.
Paired proportions were compared using McNemar’s exact test. The
pattern of ischaemia determined by both techniques for patients with
angiographic 3VD was compared using Cohen’s kappa statistic. MIB%
was compared across 1VD, 2VD, and 3VD groups using one-way analysis
of variance and Tukey’s post hoc test. Receiver-operator characteristic
(ROC) curve analyses were performed on summed perfusion scores
for individual territories and onMIB% per patient. Area-under-the-curve
(AUC) for both imaging techniques were compared using methods
described by DeLong and DeLong. All tests were two-tailed and P,
0.05 was considered statistically significant.
Results
Study population
A total of 105 patientswere enrolled into the study, including 35with
3VD byQCA.Of these 35 patients, 32 qualified as angiographic 3VD
on thebasisof significant stenoses in theproximal coronary segments
and no patients qualified as angiographic 3VD on the basis of distal
coronary segment disease. Further demographics are given in
Table 1. All 14 patients with a clinical history of MI (but no additional
patients) had evidence of hyperenhancement on LGE imaging.
A chronic total occlusion (CTO) was seen in six patients (all in the
Figure1 Case example. Standard andhigh-resolution stress perfusionCMR in a patientwith three-vessel coronary artery disease. Standard-reso-
lution shows perfusion defects (arrows) in the basal-inferior (A), mid-inferior, mid-inferoseptal (B), apical-anterior and apical-inferior segments (C).
High-resolution shows a similar distribution of perfusion defects but demonstrates additional ischaemia in the basal-lateral (D), mid-anterior, and
mid-anterolateral segments (E) with a circumferential defect in the apical slice (F ). Perfusion defects are also better delineated at high-resolution
and the transmural extent of ischaemia more clearly seen.
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group with prior MI) and two of these patients were in the 3VD
group. There were no patients with more than one CTO. In two
cases of CTO (neither in the 3VD group) there was mild collateral
flow (RC ¼ 2), but in the remaining four cases there was no or
minimal collateralization (RC ≤ 1).
Image quality and artefacts
There was no significant difference in the haemodynamic stress re-
sponse during standard- and high-resolution imaging (rate–pressure
product, mmHg × beats/min: 10 251+ 2321 vs. 10 201+ 2109;
P ¼ 0.92). No images were graded as unusable and therefore there
were no exclusions from the image analysis for either technique.
Image quality (median score ¼ 3 for both; P ¼ 0.67) and artefact
scores (median ¼ 0 for both; P ¼ 0.06) were similar for both
standard- and high-resolution imaging across the full spectrum of
patients (n ¼ 105). DRA was significantly less frequent with high-
resolution (7% vs. 26%; P ¼ 0.03) and when it did occur, it was less
marked than with standard-resolution (1.6+0.2 vs. 3.2+ 0.8 mm;
P ¼ 0.004). Seven high-resolution data sets (10%) were affected by
k-t reconstruction artefacts at stress and/or rest due to respiratory
motion, but this did not affect myocardial contrast passage and gen-
erally occurred at the end of a breath hold.
Detection of 3VD pattern
In patients with angiographic 3VD (n ¼ 35), perfusion defects in all
three territoriesweredetected in 29%of patients (10of 35) by stand-
ard-resolution and in 57% of patients (20 of 35) by high-resolution
imaging (P ¼ 0.04) (Figure 2A). Overall, there was poor agreement
between the two techniques in determining the pattern of ischaemia
in patients with angiographic 3VD [kappa ¼ 0.09, 95% confidence
interval (CI): 20.10–0.29] (Figure 2B).
Table 1 Patient clinical characteristics (n5 105)
Age, years 68+10
Males 75 (71)
Medical history
Hypertension 65 (62)
Hypercholesterolaemia 62 (59)
Diabetes mellitus 18 (17)
Smoking 43 (41)
Family history of CAD 39 (37)
Previous MI 14 (13)
Previous PCI 10 (9)
Atrial fibrillation 1 (1)
LV ejection fraction, % 55+11
Angiography findingsa
No significant disease 35 (33)
One-vessel disease 25 (24)
Two-vessel disease 10 (9)
Three-vessel disease 35 (33)
LAD disease 51 (49)
LCX disease 50 (48)
RCA disease 49 (47)
Significant lesions per patient 1.4+1.2
Total significant lesions 150
70–90% stenoses 109 (73)
90–99% stenoses 35 (23)
Chronic total occlusions 6 (4)
Values are mean+ SD or n (%). MI, myocardial infarction; PCI, percutaneous
coronary intervention; LAD, left anterior descending coronary artery; LCX, left
circumflex coronary artery; RCA, right coronary artery.
aSignificant coronary artery disease (CAD) defined as coronary stenosis ≥70% on
quantitative coronary analysis.
Figure 2 Distribution of ischaemia detected by perfusion CMR. (A) In patients with 3VD (n¼ 35), hypoperfusion in all three territories was detected in
57% using high-resolution imaging but in only 29% using standard-resolution (P¼ 0.04). (B) There was also poor agreement between high-resolution and
standard-resolution imaging in determining the distribution of ischaemia in patients with 3VD (kappa¼ 0.09, 95% CI: 20.10–0.29). IT¼ ischaemic
territories.
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Detection of CAD in each territory
In patientswith angiographic 3VD(n ¼ 35), separateROCanalysesof
perfusion scores for each of the three coronary territories were per-
formed. The AUC for each territory in patients with angiographic 3VD
was greater with high-resolution than with standard-resolution imaging,
but reached statistical significance only for the LCX territory (Table 2).
With standard-resolution imaging, diagnostic accuracy was signifi-
cantly lower for theLCX than for theLAD(0.62 vs. 0.82; P, 0.01) or
RCA territory (0.62 vs. 0.83; P ¼ 0.02). With high-resolution,
diagnostic accuracies were more homogenous between territories
(although still lowest in the LCX territory) with no statistical
difference between them (LAD: 0.85 vs. LCX: 0.83 vs. RCA: 0.90;
all P-values .0.05).
Detection of subendocardial ischaemia
Five hundred and sixty myocardial segments were available from the
35patientswith angiographic 3VD.Of these, 420weredeterminedas
angiographically hypoperfused and used for further analysis. With
high-resolution acquisition, significantly more of these hypoperfused
segments were determined as having subendocardial ischaemia than
with standard-resolution (195 vs. 101; P, 0.0001); and there was a
significant reduction in the number of segments determined as being
normal (135 vs. 212; P, 0.001) or inconclusive (15 vs. 40; P,
0.001). The number of segments assessed as having transmural is-
chaemia was similar with both techniques (75 vs. 67; P ¼ 0.25)
(Figure 3).
Detection of ischaemic burden
In patients with angiographic 3VD (n ¼ 35), the overall extent of
myocardial ischaemia detected was significantly greater with high-
resolution than standard-resolution imaging, with more abnormal
segments per patient (7.2+ 3.8 vs. 5.3+ 4.0; P ¼ 0.004), more ab-
normal territories per patient (2.4+ 0.9 vs. 1.6+1.1; P ¼ 0.002),
a higher perfusion score per territory (5.9+4.3 vs. 4.7+ 5.0; P ¼
0.01) and a higher overall perfusion score per patient (20.1+ 7.7
vs. 11.9+9.4; P, 0.0001) (Figure 1 and Table 3).
When the full spectrum of 105 patients were assessed, high-
resolution imaging found a significant upward trend in estimated
MIB% in those with significant CAD (n ¼ 70) across advancing
disease groups (1VD: 12+ 7% vs. 2VD: 39+ 15% vs. 3VD: 42+
16%; P, 0.0001).16 However, with standard-resolution, there was
no discriminate difference in estimated MIB% across the disease
groups (1VD: 21+ 11% vs. 2VD: 25+6% vs. 3VD: 25+ 19%; P ¼
0.53) (Figure 4A).
Accordingly, on ROC analysis, the AUC for detecting angiographic
3VD using the estimated MIB% was significantly greater with
high-resolution (AUC ¼ 0.90, 95% CI: 0.84–0.96) than standard-
resolution (AUC¼ 0.69, 95% CI: 0.62–0.76; P, 0.0001) (Figure 4B)
imaging. For high-resolution imaging the optimal MIB% threshold to
detect angiographic 3VD was 31% which resulted in a sensitivity and
specificity of 80% (95% CI: 64–90%) and 90% (95% CI: 80–95%),
respectively. For standard-resolution imaging, the optimal threshold
was 23%, which resulted in a sensitivity and specificity of 51% (95%
CI: 36–67%) and 78% (95% CI: 66–86%), respectively (Figure 4B).
Discussion
This study shows that in patients with angiographic 3VD, high-
resolution perfusion CMR detects a greater ischaemic burden than
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Diagnostic performance of perfusion CMR in
each territory in patients with 3VD
AUC (95% CI)
Standard-resolution High-resolution P-value
LAD 0.82 (0.69–0.95) 0.85 (0.73–0.97) 0.62
LCX 0.62 (0.46–0.79) 0.83 (0.70–0.95) 0.02
RCA 0.83 (0.70–0.95) 0.90 (0.80–1.00) 0.27
Figure 3 Distribution of transmural ischaemia index. In patients
with three-vessel disease (n ¼ 35), high-resolution perfusion
CMR determined significantly more segments as having subendo-
cardial ischaemia and fewer as normal or inconclusive compared
with standard-resolution imaging.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Detection of ischaemic burden with perfusion
CMR in patients with 3VD
Standard-
resolution
High-
resolution
P-value
Mean abnormal
segments per patient
5.3+4.0 7.2+3.8 0.004
Mean abnormal
territories per
patient
1.6+1.0 2.4+0.9 0.002
Mean perfusion score
per patient
11.9+9.4 20.1+7.7 ,0.0001
Mean perfusion score
per territory
4.7+5.0 5.9+4.3 0.01
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standard-resolutionandmore frequently identifies a 3VDpatternof is-
chaemia due to a higher detection rate of subendocardial ischaemia.
The evidence for using perfusion CMR in patients with 3VD is
limited. Although previous studies evaluating perfusion CMR have
included patients with 3VD, they have rarely reported separate
results for this specific patient population. In the published data,
the incidence of patients with 3VD was only 2% (2 patients) in the
study by Sakuma et al., 15% (8 patients) in the study by Ishida et al.,
and 19% (7 patients) in the study by Schwitter et al.8,23,24 Although
other studies may contain larger numbers, patients with 3VD are
rarely analysed separately and they are usually grouped together
with patients found to have 2VD.7,9,25 Only one study to date has
been specifically designed to evaluate standard-resolution perfusion
CMR in patients with 3VD (n ¼ 78) and it demonstrated a sensitivity
of 85% for CAD detection and superiority of perfusion CMR com-
pared with SPECT.6 Data on the use of high-resolution perfusion
CMR in the specific 3VD population are even scarcer. However, in
a recent relatedanalysis,we reportedon38patientswith angiograph-
ic multi-vessel disease (24 had 3VD) and found a greater diagnostic
accuracy for the detection of CAD (any perfusion defect) with high-
resolution perfusion CMR compared with standard-resolution
imaging (AUC, 0.98 vs.0.91; P, 0.002), but the pattern of perfusion
defects detected and the ischaemic burden were not assessed.16
Detection of subendocardial ischaemia
The finding in the present study indicates that high-resolution acqui-
sition identified significantlymore ischaemic segments and in particu-
lar more segments with subendocardial ischaemia in angiographic
3VD is consistent with the expected improvement in subendocardial
definitionwith higher spatial resolution.Althoughwehavepreviously
demonstrated this finding across the full spectrum of CAD, it was
important to confirm that this advantage is maintained in the 3VD
population against the competing challenge of balanced ischaemia.16
It means that one of the major limitations of myocardial perfusion
imaging and visual analysis in 3VD, i.e. its dependence on a reference
areaof normal perfusion, can beovercome to someextentwith high-
resolution techniques that are able to resolve subendocardial ischae-
mia and transmural perfusion gradients, reducing the need for intra-
patient comparison. An alternative approach is quantitative analysis of
standardperfusionCMRand although this has been shown to identify
patients with 3VD better than visual analysis, it remains a time-
consuming research tool until technical developments lead to
greater automation.21 The significant reduction of DRA with high-
resolution may also partially account for its improved detection of
subendocardial ischaemia and notably therewere fewer inconclusive
segments with high-resolution acquisition compared with standard-
resolution (Figure 3). Previouswork investigatingDRAhas shown the
prominent role of spatial resolution on the occurrence and extent of
this artefact.17,20
Detection of 3VD pattern
Standard-resolution perfusion CMR identified defects in all three
perfusion territories in only 29% of patients with angiographic 3VD
(10 of 35) (Figure 2B). In the published CMR literature, there is only
one study that investigates the same question and it found a signifi-
cantly greater figure of over 50% using standard-resolution techni-
ques.6 However, this previous retrospective study only analysed
patients with 3VD, without a control group; and additionally did
not use LGE imaging to exclude areas of infarction from inducible is-
chaemia, both of which are likely to have led to a positive bias. In the
comparative SPECT literature, we see the ability to detect a 3VD
Figure4 Myocardial ischaemic burden (MIB). (A) In patientswith significant coronary artery disease (n ¼ 70), high-resolution perfusionCMRwas
able to detect significant differences in MIB across disease categories unlike standard-resolution imaging (error bars ¼ SEM). (B) The AUC for
detecting 3VD using MIB among patients with suspected angina (n ¼ 105) was significantly greater with high-resolution than standard-resolution
(AUC ¼ 0.90 vs. 0.69; P, 0.0001). VD ¼ vessel disease.
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pattern is similarly only 29% in one series and as low as 12% in
another.2,6
With the high-resolution perfusion CMR method, twice as many
patients with angiographic 3VD, i.e. 57% (20 of 35) were correctly
classified as having a 3VD pattern of ischaemia (Figure 2B). The
improved detection of a 3VD pattern of ischaemia with high-
resolution compared with standard-resolution acquisition was due
to better detection of ischaemia in the LCX territory and more sub-
endocardial ischaemia detection.Diseaseof the LCX territory can be
difficult to detect because this territory is farthest from the radiofre-
quency coil and because visual, unlike quantitative assessment ana-
lysis, cannot correct signal intensity for distance from the coil.6,26 In
keeping with previous studies, high-resolution acquisition used a
higher contrast dose (in order to compensate for the lower SNR
associated with smaller voxel size) and arguably this may have con-
tributed to its superior performance in the LCX territory.13,14,16,17
Rather than inadequacyof theperfusionanalysis, the lowdetection
rate of ischaemia in multiple territories by different imaging modal-
ities may reflect at least in part the inadequacy of the purely anatom-
ical angiographic endpoint in these studies including our own. In a
sub-analysis of the FAMEstudy, only 14%of patientswith angiograph-
ic 3VD (n ¼ 115) had concordant three-vessel functional disease
determined by fractional flow reserve (FFR) (i.e. FFR, 0.80 in all
three vessels).27
Estimation of ischaemic burden
It can be argued that in clinical practice, it is less relevant whether a
functional scan depicts a typical three-vessel pattern if there is myo-
cardial ischaemia involving a significant proportion of total myocar-
dium. An accurate assessment of ischaemic burden is important
because the extent of ischaemia is a marker of patient prognosis—
and a large ischaemic burden supports aggressive medical treatment
and angiography with a view to revascularization regardless of the
territorial pattern of perfusion defect.19,28–30 When MIB% was
estimated using high-resolution CMR, it was found to reliably dis-
criminate angiographic 3VD from less extensive disease and nor-
mal controls (AUC ¼ 0.89) (Figure 4). This was not the case for
standard-resolution CMR, for which MIB% had a significantly
poorer diagnostic accuracy (AUC ¼ 0.69; P, 0.0001) and was not
able to reliably differentiate between patients with 1VD, 2VD, or
3VD (Figure 4). The latter observation regarding standard-resolution
perfusionCMRhas been previously noted by Patel et al.21who found
similar estimates of ischaemic burden in patients with angiographic
single-vessel disease and 3VD with visual assessment (21% vs. 31%;
P ¼ 0.26), but a significant difference if quantified with myocardial
perfusion reserve analysis (25%vs. 60%;P ¼ 0.02).A similar phenom-
enon has been described with positron emission tomography.31
High-resolution perfusion CMR acquisition appears to overcome
this limitation seen with lower spatial resolution imaging methods.
Although there is no agreed reference standard for MIB%, the
current data suggest that standard-resolution imaging underesti-
mates MIB%—and this should be considered in the interpretation
of future perfusion CMR studies that may use a particular threshold
of ischaemic burden as a defined end-point or inclusion criteria. In
the nuclear sub-study of COURAGE, patients with a MIB% .10%
had a lower risk of death or MI if they underwent revascularization
rather than optimal medical therapy alone.30 Notably, there has
been no direct comparison of CMR and SPECT for MIB% assess-
ment—but if the threshold defined for SPECT is applied to the
CMR data in this study, 24 of 35 patients with angiographic 3VD
had anMIB%.10% using standard-resolution perfusion CMR, com-
pared with 33 patients with the high-resolution technique. Thus,
high-resolution perfusion CMR may offer an improved non-invasive
assessment of ischaemic burden and help identify the optimal thera-
peutic approach.
Study limitations
Our findings are mainly technical, and further studies with clinical
outcomedatawouldbe required to support theproposed incremen-
tal value of high-resolution perfusion CMR. We also accept that
although we hypothesize the superior performance of high-
resolution perfusion CMR relates to greater spatial resolution and
better detection of subendocardial ischaemia, we cannot exclude
the influence of other factors such as differences in SNR between
scans and the difference in contrast protocols used as compensation.
A functional endpoint such as FFR would have been preferable—
but this is not easily achievable given the logistics of performing
multiple FFR assessments on serial and complex stenoses in three dif-
fusely diseased arteries to define each subject. However, our findings
predominantly relate to comparative differences in ischaemic burden
assessment between the two techniques rather than their absolute
ability to detect any ischaemia.
Because the visual CMR analysis was performed by two observers
acting in consensus, inter-observer and intra-observer variability for
perfusion scoring was not tested; however, arbitration from a third
reader was only required in 5 out of the 210 analyses (3 with stand-
ard-and 2 with high-resolution).
Finally, quantitative methods for the estimation of myocardial
blood flow (MBF) based on perfusion CMR data have been validated
in animal models and applied to clinical studies.21 However, in this
study, contrast agent dose and administration (single-bolus tech-
nique) were optimized for visual analysis and therefore quantitative
analysis was not performed. Although high-resolution perfusion
CMR offers further intriguing opportunities for quantitative analysis
the algorithms applied for the reconstruction of high-resolution per-
fusion CMR data acquired with temporospatial undersampling
methods give rise to a degree of low-pass temporal filtering, posing
additional challenges to quantitation of MBF including an underesti-
mation bias.32,33 Recent developments such as k-t principal compo-
nent analysis are likely to overcome some of these challenges but
will require evaluation in future studies.34
Conclusions
High-resolution perfusion CMR increases the observed ischaemic
burden and distribution of ischaemia detected in angiographic 3VD.
The incremental value of high-resolution acquisition for correctly
identifying, stratifying, and managing this high-risk group has to be
determined in further clinical studies.
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